A detailed history of Strategic Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Strategic Asset Management, LLC holds 200 shares of BMY stock, worth $11,552. This represents 0.02% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$11,552
Previous $15,000 6.67%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022

SELL
$53.63 - $62.52 $42,904 - $50,016
-800 Reduced 80.0%
200 $12,000
Q3 2021

Nov 04, 2021

BUY
$59.17 - $69.31 $59,170 - $69,310
1,000 New
1,000 $59,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Strategic Asset Management, LLC Portfolio

Follow Strategic Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Asset Management, LLC with notifications on news.